astrazeneca glp 1 drug AstraZeneca’s experimental obesity pill helped patients lose up to 11.8% of their body weight in a mid-stage trial, as competition intensifies in the rapidly growing market for oral weight-loss drugs. AstraZeneca launches GLP-1 combo to

Folate losses in ultra-heat treated milk packed in Tetra Pak stored at 24 C amounted to 11% and 32% after 12 and 20 weeks, respectively 463

This post explains what Lemon Bottle actually is, why the regulators have flagged it, what the safer regulated alternative looks like, and how we handle Lemon Bottle enquiries at CoLaz when a patient asks for it by name

Any use for NAFLD/NASH would be considered off-label

My clients have started to report this very thing

While CBP/p300 is a well-validated direct interaction partner of NRF2 with prominent functions at enhancers, we report that this interaction is not required for NRF2-dependent NSCLC cell growth, indicating that NRF2 can sustain sufficient transcriptional activity in the absence of CBP/p300 coactivation